Christoph Sarrazin
Frankfurt Am Main, HE, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 69 publications
Hyperlipasemia following therapy with direct antiviral drugs in patients with chronic hepatitis C virus infection - data from the German Hepatitis C Registry (DHC-R)
Journal: Zeitschrift fur Gastroenterologie
Published: April 22, 2026
Clinical characteristics of newly diagnosed patients with primary biliary cholangitis (PBC) indicate the need for better awareness on timely diagnosis and adequate UDCA therapy.
Journal: Zeitschrift fur Gastroenterologie
Published: December 09, 2025
Resolved HBV Infection Is Not Associated With Liver-Related Outcomes in Survival Analysis of Caucasians After HCV Cure.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: September 09, 2025
Core curriculum of intensive care and emergency medicine in internal medicine
Journal: Medizinische Klinik, Intensivmedizin und Notfallmedizin
Published: May 14, 2025
Transjugular diagnostic procedures in hepatology: Indications, techniques and interpretation.
Journal: JHEP reports : innovation in hepatology
Published: November 28, 2024
Acid Sphingomyelinase Activation and ROS Generation Potentiate Antiproliferative Effects of Mitomycin in HCC.
Journal: International journal of molecular sciences
Published: October 20, 2024
Sub-optimal therapy of patients with primary biliary cholangitis (PBC) in the real-life stetting of the German PBC cohort.
Journal: Zeitschrift fur Gastroenterologie
Published: September 03, 2024
Hepatitis C: From diagnosis to global virus elimination
Journal: Deutsche medizinische Wochenschrift (1946)
Published: August 02, 2024
Reply to: "Unlocking hope: HCV re-treatment strategy for patients with active hepatocellular carcinoma".
Journal: JHEP reports : innovation in hepatology
Published: August 01, 2024
Updated Results from the Retrospective CREST Study on the Safety and Effectiveness of 8-Week Glecaprevir/Pibrentasvir in HCV-Infected Treatment-Naïve Patients with Compensated Cirrhosis.
Journal: Advances in therapy
Published: May 21, 2024
Last Updated: 09/26/2026